Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in ICU — SeaStar Medical Holding Corp

CIK 886982 NEW YORK, NY
Back to ICU Full portfolio

Position in ICU

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
211,381
0.0% QoQ
Ownership
4.80%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ICU Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. ICU ranks #356 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in ICU

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2025-12-31 $5,568 23,204
2025-09-30 $10,822 18,986
2025-06-30 $5,292 12,424
2025-03-31 $16,938 10,204
2024-12-31 $19,931 10,274
2024-03-31 $7,747 10,555
2023-12-31 $4,538 10,245
2023-09-30 $2,703 10,240
2023-06-30 $5,288 10,170
2023-03-31 $18,914 10,169
2022-12-31 $42,922 10,469